Twist Bioscience Corporation provided revenue guidance for the second quarter of fiscal year 2024. Total revenue of approximately $70 million to $71 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
46.98 USD | +6.75% | +10.70% | +27.46% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.46% | 2.56B | |
-0.48% | 90.85B | |
-0.92% | 39.02B | |
-9.57% | 33.46B | |
-17.98% | 14.51B | |
-6.74% | 13.22B | |
-9.76% | 11.65B | |
-47.31% | 10.57B | |
+6.52% | 9.23B | |
+137.06% | 7.71B |
- Stock Market
- Equities
- TWST Stock
- News Twist Bioscience Corporation
- Twist Bioscience Corporation Provides Revenue Guidance for the Second Quarter of Fiscal Year 2024